CoChat
Sign Up
Cited by 65

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Very Low Density Lipoprotein Receptor (VLDLR) Expression Is a Determinant Factor in Adipose Tissue Inflammation and Adipocyte-Macrophage Interaction

Nguyen, Andrew, Tao, Huan, Metrione, Michael, Hajri, Tahar·2014·Journal of Biological Chemistry
DOI 10.1074/jbc.m113.515320
Open this paper in CoChat — free account

Abstract

Obesity is associated with adipose tissue remodeling, characterized by adipocyte hypertrophy and macrophage infiltration. Previously, we have shown that very low density lipoprotein receptor (VLDLR) is virtually absent in preadipocytes but is strongly induced during adipogenesis and actively participates in adipocyte hypertrophy. In this study, we investigated the role of VLDLR in adipose tissue inflammation and adipocyte-macrophage interactions in wild type and VLDLR-deficient mice fed a high fat diet. The results show that VLDLR deficiency reduced high fat diet-induced inflammation and endoplasmic reticulum (ER) stress in adipose tissue in conjunction with reduced macrophage infiltration, especially those expressing pro-inflammatory markers. In adipocyte culture, VLDLR deficiency prevented adipocyte hypertrophy and strongly reduced VLDL-induced ER stress and inflammation. Likewise, cultures of primary peritoneal macrophages show that VLDLR deficiency reduced lipid accumulation and inflammation but did not alter chemotactic response of macrophages to adipocyte signals. Moreover, VLDLR deficiency tempered the synergistic inflammatory interactions between adipocytes and macrophages in a co-culture system. Collectively, these results show that VLDLR contributes to adipose tissue inflammation and mediates VLDL-induced lipid accumulation and induction of inflammation and ER stress in adipocytes and macrophages.

Overview

Integrity signals

Registry

Crossref · 10.1074/jbc.m113.515320

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 47

  1. Olefsky, 2010, Macrophages, inflammation, and insulin resistance, Annu. Rev. Physiol, 72, 219, 10.1146/annurev-physiol-021909-135846 · DOI · Paper page
  2. Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J. Clin. Invest, 112, 1796, 10.1172/JCI200319246 · DOI · Paper page
  3. Nguyen, 2005, JNK and tumor necrosis factor-α mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes, J. Biol. Chem, 280, 35361, 10.1074/jbc.M504611200 · DOI · Paper page
  4. Schenk, 2008, Insulin sensitivity: modulation by nutrients and inflammation, J. Clin. Invest, 118, 2992, 10.1172/JCI34260 · DOI · Paper page
  5. Gregor, 2007, Thematic review series: Adipocyte Biology. adipocyte stress: the endoplasmic reticulum and metabolic disease, J. Lipid Res, 48, 1905, 10.1194/jlr.R700007-JLR200 · DOI · Paper page
  6. Sun, 2011, Adipose tissue remodeling and obesity, J. Clin. Invest, 121, 2094, 10.1172/JCI45887 · DOI · Paper page
  7. Cinti, 2005, Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans, J. Lipid Res, 46, 2347, 10.1194/jlr.M500294-JLR200 · DOI · Paper page
  8. Ajuwon, 2005, Palmitate activates the NF-κB transcription factor and induces IL-6 and TNFα expression in 3T3-L1 adipocytes, J. Nutr, 135, 1841, 10.1093/jn/135.8.1841 · DOI · Paper page
  9. Takahashi, 2008, JNK- and IκB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro, Am. J. Physiol. Endocrinol. Metab, 294, E898, 10.1152/ajpendo.00131.2007 · DOI
  10. Yagyu, 2002, Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency, J. Biol. Chem, 277, 10037, 10.1074/jbc.M109966200 · DOI · Paper page
  11. Takahashi, 1995, Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase, J. Biol. Chem, 270, 15747, 10.1074/jbc.270.26.15747 · DOI
  12. Tao, 2010, Peroxisome proliferator-activated receptor-γ regulates the expression and function of very-low density lipoprotein receptor, Am. J. Physiol. Endocrinol. Metab, 298, E68, 10.1152/ajpendo.00367.2009 · DOI
  13. Frykman, 1995, Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor, Proc. Natl. Acad. Sci. U.S.A, 92, 8453, 10.1073/pnas.92.18.8453 · DOI · Paper page
  14. Goudriaan, 2004, The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis, J. Lipid Res, 45, 1475, 10.1194/jlr.M400009-JLR200 · DOI · Paper page
  15. Goudriaan, 2001, Protection from obesity in mice lacking the VLDL receptor, Arterioscler. Thromb. Vasc. Biol, 21, 1488, 10.1161/hq0901.095147 · DOI · Paper page
  16. Obunike, 2001, Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor, J. Biol. Chem, 276, 8934, 10.1074/jbc.M008813200 · DOI · Paper page
  17. Tao, 2011, Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists, Biochem. Pharmacol, 82, 1950, 10.1016/j.bcp.2011.09.003 · DOI
  18. Crawford, 2008, A common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease risk, J. Lipid Res, 49, 588, 10.1194/jlr.M700409-JLR200 · DOI
  19. Boycott, 2005, Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification, Am. J. Hum. Genet, 77, 477, 10.1086/444400 · DOI
  20. Chen, 2012, Up-regulation of ATP binding cassette transporter A1 expression by very low density lipoprotein receptor and apolipoprotein E receptor 2, J. Biol. Chem, 287, 3751, 10.1074/jbc.M111.310888 · DOI
  21. Du, 2012, Macrophage VLDL receptor promotes PAFAH secretion in mother's milk and suppresses systemic inflammation in nursing neonates, Nat. Commun, 3, 1008, 10.1038/ncomms2011 · DOI
  22. Hajri, 2011, Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6, Am. J. Physiol. Endocrinol. Metab, 300, E350, 10.1152/ajpendo.00307.2010 · DOI
  23. Hajri, 2002, Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice, J. Clin. Invest, 109, 1381, 10.1172/JCI0214596 · DOI
  24. Ueda, 2011, Reduction of 8-iso-prostaglandin F2α in the first week after Roux-en-Y gastric bypass surgery, Obesity, 19, 1663, 10.1038/oby.2011.58 · DOI
  25. Hajri, 2007, CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue, Diabetes, 56, 1872, 10.2337/db06-1699 · DOI · Paper page
  26. Bastie, 2004, CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness, Diabetes, 53, 2209, 10.2337/diabetes.53.9.2209 · DOI
  27. Patsouris, 2009, Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage chemotaxis and recruitment, J. Biol. Chem, 284, 31223, 10.1074/jbc.M109.041665 · DOI
  28. Hajri, 1998, Myristic acid-rich fat raises plasma LDL by stimulating LDL production without affecting fractional clearance in gerbils fed a cholesterol-free diet, J. Nutr, 128, 477, 10.1093/jn/128.3.477 · DOI
  29. Hajri, 2001, Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy, J. Biol. Chem, 276, 23661, 10.1074/jbc.M100942200 · DOI
  30. McFarlane, 1958, Efficient trace-labelling of proteins with iodine, Nature, 182, 53, 10.1038/182053a0 · DOI
  31. Lumeng, 2007, Obesity induces a phenotypic switch in adipose tissue macrophage polarization, J. Clin. Invest, 117, 175, 10.1172/JCI29881 · DOI · Paper page
  32. Kaufman, 1999, Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls, Genes Dev, 13, 1211, 10.1101/gad.13.10.1211 · DOI
  33. Cai, 2012, Scavenger receptor CD36 expression contributes to adipose tissue inflammation and cell death in diet-induced obesity, PLoS One, 7, e36785, 10.1371/journal.pone.0036785 · DOI
  34. Ito, 2007, Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy, J. Biol. Chem, 282, 25445, 10.1074/jbc.M701549200 · DOI
  35. Gao, 2007, Involvement of apolipoprotein E in excess fat accumulation and insulin resistance, Diabetes, 56, 24, 10.2337/db06-0144 · DOI
  36. Wang, 2012, ApoE and the role of very low density lipoproteins in adipose tissue inflammation, Atherosclerosis, 223, 342, 10.1016/j.atherosclerosis.2012.06.003 · DOI
  37. Chiba, 2003, VLDL induces adipocyte differentiation in ApoE-dependent manner, Arterioscler. Thromb. Vasc. Biol, 23, 1423, 10.1161/01.ATV.0000085040.58340.36 · DOI
  38. Huang, 2009, Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo, Am. J. Physiol. Endocrinol. Metab, 296, E1110, 10.1152/ajpendo.90964.2008 · DOI
  39. Huang, 2009, Mechanism for endogenously expressed apoE modulation of adipocyte very low density lipoprotein metabolism: role in endocytic and lipase-mediated metabolic pathways, J. Biol. Chem, 284, 31512, 10.1074/jbc.M109.004754 · DOI
  40. Strissel, 2007, Adipocyte death, adipose tissue remodeling, and obesity complications, Diabetes, 56, 2910, 10.2337/db07-0767 · DOI · Paper page
  41. Cancello, 2005, Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss, Diabetes, 54, 2277, 10.2337/diabetes.54.8.2277 · DOI · Paper page
  42. Oh, 2012, Increased macrophage migration into adipose tissue in obese mice, Diabetes, 61, 346, 10.2337/db11-0860 · DOI
  43. Shapiro, 2013, Adipose tissue foam cells are present in human obesity, J. Clin. Endocrinol. Metab, 98, 1173, 10.1210/jc.2012-2745 · DOI
  44. Satoh, 2010, Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone, Diabetes Care, 33, e7, 10.2337/dc09-1315 · DOI
  45. He, 2011, Markers of adipose tissue macrophage content are negatively associated with serum HDL-C concentrations, Atherosclerosis, 215, 243, 10.1016/j.atherosclerosis.2010.12.018 · DOI
  46. Ahlin, 2013, Macrophage gene expression in adipose tissue is associated with insulin sensitivity and serum lipid levels independent of obesity, Obesity, 21, 10.1002/oby.20443 · DOI
  47. Coenen, 2007, Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue, Diabetes, 56, 564, 10.2337/db06-1375 · DOI

Cited by

Sorted by citations

Metadata

Authors
Nguyen, A., Tao, H., Metrione, M., & Hajri, T.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2014-01
Volume
289
Issue
3
Pages
1688-1703
ISSN
0021-9258
DOI
10.1074/jbc.m113.515320
Cited by
65
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review